View drug registration information details.
Items | Registration information |
ID | 87 |
No | 87 |
Brand Name | MINOPHAGEN C |
Ingredients | MONOAMMONIUM GLYCYRRHIZINATE 53 MG (AS GLYCYRRHIZIC ACID 40 MG), GLYCINE JP 400 MG, L-CYSTEINE HYDROCHLORIDE HYDRATE 22.29 MG (L-CYSTEINE HYDROCHLORIDE 20 MG) |
Dosage Form | SOLUTION FOR INJECTION |
Primary Packaging | AMPOULES |
Storage | STORE AT 1-25C |
Shelf Life | 36 MONTHS |
Pack Size | 20 ML/AMPOULES, BOX OF 30 AMPOULES |
Dispensing Category | PRESCRIPTION ONLY |
ATC Classification | A05BA08 |
Pharmaceutical Class | LIVER THERAPY |
Indications | ECZEMA OR DERMATITIS, URTICARIA, PRURITUS, DRUG ERUPTION OR TOXICODERMA, STOMATITIS, INFANT STROPHULUS, PHLYCTEN. IMPROVEMENT OF ABNORMAL HEPATIC FUNCTION IN CHRONIC LIVER DISEASES. |
Contraindications | HISTORY OF HYPERSENSITIVITY, PATIENTS WITH ALDOSTERONISM, MYOPATHY AND HYPOKALAEMIA |
Side Effects | RASH, UPPER ABDOMINAL DISCOMFORT |
Unit Price | |
EDL |
No |
Description | COLORLESS, CLEAR AQUEOUS INJECTION IN GLASS AMPOULES |
Note | |
License Owner | AI KEN PHARMA CO., LTD |
Manufacturer | MINOPHAGEN PHARMACEUTICAL CO.,LTD., ZAMA FACTORY |
Country | JAPAN |
Import Registration No | 21900AMX00144000 |
Import Registration Date | 2007-02-28 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-11-29 |
FDD Registration No | 02 I 5204/22 |
FDD Registration Date | 2024-12-16 |
Expiry Date | 2029-12-15 |
Back to drug list
|